Gallacher Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$454K	Buy	24,520 +2,839	+13%	+$49.8K	0.17%	169
2025 Q4	$338K	Sell	21,681 -5,564	-20%	-$79.5K	0.13%	212
2025 Q3	$399K	Buy	27,245 +5,245	+24%	+$77.9K	0.16%	203
2025 Q2	$340K	Buy	22,000 +2,507	+13%	+$37K	0.16%	187
2025 Q1	$290K	Buy	19,493 +1,854	+11%	+$26K	0.14%	196
2024 Q4	$234K	Buy	17,639 +415	+2%	+$5.7K	0.12%	241
2024 Q3	$245K	Sell	17,224 -141	-0.8%	-$2K	0.11%	235
2024 Q2	$225K	Buy	17,365 +1,136	+7%	+$15K	0.12%	230
2024 Q1	$225K	Buy	16,229 +927	+6%	+$13.5K	0.11%	227
2023 Q4	$218K	Sell	15,302 -148	-1%	-$2.1K	0.12%	229
2023 Q3	$239K	Buy	15,450 +220	+1%	+$3.41K	0.15%	189
2023 Q2	$239K	Buy	15,230 +1,205	+9%	+$19.7K	0.14%	204
2023 Q1	$231K	Buy	14,025 +2,967	+27%	+$47.3K	0.14%	202
2022 Q4	$173K	Buy	+11,058	New	+$154K	0.1%	222